Read the latest press releases for 4D pharma plc.
Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.
Press release archive
2 Jul 2020, 07:00
Phase II study of MRx-4DP0004 in patients hospitalized with COVID-19 open for enrolment.
Dosing of…
5 Jun 2020, 07:45
4D's Chairman, CEO and CSO provide updates on the company’s clinical programmes in oncology and…
11 May 2020, 07:30
4D pharma plc announces successful completion of Part A of a Phase I/II clinical trial of MRx0518 in…
20 Apr 2020, 07:00
4D announces expedited UK regulatory acceptance to commence Phase II study in COVID-19
17 Apr 2020, 08:00
4D pharma plc today announces the key findings of a planned interim analysis in its BHT-II-0002…
17 Apr 2020, 08:00
4D pharma today announces that Prof. Axel Glasmacher, MD, has been appointed as Non-Executive…
17 Mar 2020, 08:00
4D presents an update on the previously reported interim data from its ongoing Phase I/II study of…
6 Jan 2020, 08:00
4D pharma announces opening of a study investigating MRx0518 in combination with radiotherapy in…
6 Nov 2019, 08:00
4D pharma plc (AIM: DDDD), a clinical-stage pharmaceutical company leading the development of Live…
8 Oct 2019, 07:00
4D pharma plc today announces that the Company has entered into a research collaboration and option…
23 Sep 2019, 09:00
4D pharma announces the publication of data highlighting the neuroprotective properties of MRx0005…
27 Aug 2019, 09:00
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics,…
25 Jul 2019, 09:00
Second-generation Live Biotherapeutic Identified and Mechanistic Data on MRx0518 and MRx1299…
8 Jul 2019, 09:00
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics,…
6 Jun 2019, 10:00
4D pharma plc (AIM: DDDD) today announced that data from the completed Phase Ib clinical study of…
